Investigation of Wnt5a and sFRP5 Expressions in Healthy and Chronic Periodontitis Tissues by Kulwattanaporn, Pacharee
University of Pennsylvania
ScholarlyCommons
Dental Theses Penn Dental Medicine
2015
Investigation of Wnt5a and sFRP5 Expressions in
Healthy and Chronic Periodontitis Tissues
Pacharee Kulwattanaporn
University of Pennsylvania
Follow this and additional works at: http://repository.upenn.edu/dental_theses
Part of the Amino Acids, Peptides, and Proteins Commons, Bacterial Infections and Mycoses
Commons, Immunology and Infectious Disease Commons, Medical Genetics Commons, Oral
Biology and Oral Pathology Commons, and the Periodontics and Periodontology Commons
This paper is posted at ScholarlyCommons. http://repository.upenn.edu/dental_theses/1
For more information, please contact libraryrepository@pobox.upenn.edu.
Recommended Citation
Kulwattanaporn, Pacharee, "Investigation of Wnt5a and sFRP5 Expressions in Healthy and Chronic Periodontitis Tissues" (2015).
Dental Theses. 1.
http://repository.upenn.edu/dental_theses/1
Investigation of Wnt5a and sFRP5 Expressions in Healthy and Chronic
Periodontitis Tissues
Abstract
Periodontitis is a biofilm-induced chronic inflammatory disease that causes gingival inflammation and
attachment loss. Destruction of periodontal tissue is a consequence of host immune inflammatory responses
induced by periodontal microorganisms. Wnt5a is strongly associated with inflammatory responses and
shown by several studies to be involved in inflammatory diseases including periodontitis. sFRP5 is a homolog
of Wnt5a receptor, frizzled protein. sFRP5 is a known inhibitor of Wnt5a signaling. To investigate the
correlation of Wnt5a and sFRP5 in periodontitis and healthy tissues, experiments were set up using both
clinical specimens and further investigation with stimulations of human gingival epithelial cells (HGECs).
Wnt5a and sFRP5 mRNA expression and protein levels were studied by immunohistochemistry, quantitative
real time PCR, and ELISA. Results showed localization of Wnt5a and sFRP5 in periodontal tissue and higher
level of Wnt5a expression in periodontitis group than in healthy group and vice versa for sFRP5 expression.
LPS from P. gingivalis or E. coli induced Wnt5a expression and reduced sFRP5 expression. Moreover, sFRP5
mediated anti-inflammatory effects by inhibiting IL-8 production in HGECs. In conclusion, inverse
correlation of Wnt5a and sFRP5 expression was shown for the first time and human gingival epithelial cells
were also proved to express both Wnt5a and sFRP5. Wnt5a appears to be an important target for intervention
in periodontitis and sFRP5 is likely a promising therapeutic compound.
Degree Type
Thesis
Degree Name
MSOB (Master of Science in Oral Biology)
Primary Advisor
George Hajishengallis
Subject Categories
Amino Acids, Peptides, and Proteins | Bacterial Infections and Mycoses | Immunology and Infectious Disease
| Medical Genetics | Oral Biology and Oral Pathology | Periodontics and Periodontology
This thesis is available at ScholarlyCommons: http://repository.upenn.edu/dental_theses/1
  
Investigation of Wnt5a and sFRP5 Expressions in      
      Healthy and Chronic Periodontitis Tissues 
 
 
 
 
 
 
Pacharee Kulwattanaporn, DDS 
 
University of Pennsylvania 
School of Dental Medicine 
Department of Endodontics 
 
 
 
 
Presented to the Faculty of the University of Pennsylvania School of Dental Medicine in 
Partial Fulfillment of the Requirements for the Degree of Master of Master of Science in 
Oral Biology 
 
 
 
 
 
 
 
Research project advisors 
 
Dr. George Hajishengallis 
 
Dr. Jonathan Korostoff 
 
 
 
 
 
 
 
 
 
 
ACKNOWLEDGEMENT 
 
 
I would like to express my appreciation to my advisor, Dr. George Hajishengallis, for the  
 
honorable opportunity to work and experience professional working environment in this  
 
laboratory. His initiation and creativity greatly contributes to my work. I also would like to thank  
 
Dr. Jonathan Korostoff for his guidance and help throughout the masters of oral biology  
 
program. 
 
I want to express my deepest gratitude to Dr. Tomoki Maekawa who helped me tremendously  
 
from day one. Without his supervision and constant help, this dissertation would not have been  
 
possible. Thank you for his dedication, patience and engagement that contributes greatly to my  
 
progress. 
 
In addition, I would like to thank Dr. Kavita Hosur and all of my postdoctoral fellows for their  
 
support both technically and mentally. They helped me thrive and enjoy the quality time in the  
 
laboratory. Finally, I would like to thank Dr. Bekir Karabucak for his understanding and support  
 
throughout this program. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT 
 
Periodontitis is a biofilm-induced chronic inflammatory disease that causes gingival  
 
inflammation and attachment loss. Destruction of periodontal tissue is a consequence of host  
 
immune inflammatory responses induced by periodontal microorganisms. Wnt5a is strongly  
 
associated with inflammatory responses and shown by several studies to be involved in  
 
inflammatory diseases including periodontitis. sFRP5 is a homolog of Wnt5a receptor,  
 
frizzled protein. sFRP5 is a known inhibitor of Wnt5a signaling. To investigate the correlation  
 
of Wnt5a and sFRP5 in periodontitis and healthy tissues, experiments were set up using  
 
both clinical specimens and further investigation with stimulations of human gingival  
 
epithelial cells (HGECs). Wnt5a and sFRP5 mRNA expression and protein levels were  
 
studied by immunohistochemistry, quantitative real time PCR, and ELISA. Results showed  
 
localization of Wnt5a and sFRP5 in periodontal tissue and higher level of Wnt5a expression  
 
in periodontitis group than in healthy group and vice versa for sFRP5 expression. LPS from  
 
P. gingivalis or E. coli induced Wnt5a expression and reduced sFRP5 expression. Moreover,  
 
sFRP5 mediated anti-inflammatory effects by inhibiting IL-8 production in HGECs. In  
 
conclusion, inverse correlation of Wnt5a and sFRP5 expression was shown for the first time  
 
and human gingival epithelial cells were also proved to express both Wnt5a and sFRP5.  
 
Wnt5a appears to be an important target for intervention in periodontitis and sFRP5 is likely a  
 
promising therapeutic compound. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LITERATURE REVIEW 
 
Introduction 
 
    It is documented that more than 47% of the adult U.S. population suffers from periodontitis  
 
and even up to 64% of adults aged 65 years and older had either moderate or severe  
 
periodontitis [1]. Considering this high prevalence, it is important to investigate the  
 
pathogenesis of periodontitis and develop effective treatments. 
 
    The inflammatory process is important in host immune defense and occurs in many parts  
 
of the body. Inflammation helps defend against pathogens and takes part in wound healing.  
 
As soon as the body encounters injury or infection, acute inflammation arises. However, if  
 
the infection persists, chronic inflammation will ensue. A good example is the oral cavity.  
 
Microorganisms are always present which can cause inflammatory response in the form of  
 
gingivitis. Gingivitis is a reversible condition and affects only the gingival tissue, whereas the  
 
underlying alveolar bone remains intact. In cases that there are other contributing factors, for  
 
example, compromised host responses or intense microbial challenge, then gingivitis may  
 
transition to periodontitis. Periodontitis is a biofilm-induced chronic inflammatory disease that  
 
causes gingival inflammation and attachment loss [2]. Destruction of periodontal tissue is a  
 
consequence of host immune inflammatory responses induced by periodontal  
 
microorganisms. In the past, researchers showed that bacteria have a major role in the  
 
pathogenesis of periodontitis [3, 4]. Later, the important role of host immune responses  
 
contributing to disease progression has been investigated and confirmed [5, 6]. Hereditary  
 
factors, systemic conditions and environmental factors were also shown to be involved [7]. 
 
    The pathogenesis of periodontitis involves complex interactions between the microbial  
challenge and host response that alters connective tissue and bone metabolism. In biofilm,  
numerous bacterial strains reside. In the past, employing culturing techniques, a few bacteria  
have been designated as periodontal pathogens. These bacteria constitute the so-called “red  
complex” and include Tannerella forsythia, Porphyromonas gingivalis, and Treponema  
denticola [8]. These three major strains of bacteria were thought to contribute to progression  
of periodontitis. However, the advent of culture-independent, molecular-based methods of  
bacterial identification has changed our understanding of the bacterial composition of the  
periodontal region [2]. Nowadays, it is widely accepted that periodontitis is not caused by  
single or a limited group of pathogens, but rather caused by polymicrobial synergy and  
dysbiosis [9]. 
    According to the polymicrobial synergy and dysbiosis (PSD) model, several kinds of  
bacteria exhibit synergistic interactions that promote colonization, persistence, or virulence  
orchestrated by keystone pathogens. P. gingivalis is a keystone pathogen that modulates the  
host response and tips the balance from homeostasis to dysbiosis which enables only  
certain kinds of bacteria to thrive and persist in the host. Inflammation has a major role that  
selects members of bacterial community in the way that only inflammophilic bacteria can  
survive. These bacteria are not destroyed by inflammation but fed on inflammatory  
breakdown products as a source of nutrients. Therefore, this selective mechanism causes  
the flourishing of inflammophilic bacteria which helps perpetuate tissue destruction that  
finally loops back to serve as nutrient source for these bacteria, thereby generating a vicious  
cycle [10]. 
    Bacterial antigens, LPS, and toxins from biofilm stimulate host immune response. Once  
stimulated, immune cells such as PMN, and humoral and cell-mediated response are  
directed to reduce the bacterial challenge. This results in the production of inflammatory  
mediators such as cytokines, chemokines, prostaglandins and proteolytic enzymes that alter  
connective tissue and bone metabolism. If host immune system cannot cause resolution of  
these inflammatory processes, then periodontal inflammation and periodontal damage will  
follow[7]. 
    The Wnt signaling protein family has a significant role in the developmental events of  
multicellular organisms. Wnts is a large family of cysteine-rich secreted ligands that are  
essential in the regulation of embryogenesis, development, proliferation, polarity, migration,  
and invasion. Historically, there are two groups of Wnt proteins; the group that activates the  
beta-catenin-dependent pathway (canonical) and the group that activates beta-catenin- 
independent pathway (non-canonical). Wnt1, Wnt3, Wnt3a, and Wnt7a are the canonical  
Wnts which stabilize beta-catenin, while Wnt5a, Wnt5b, Wnt6, Wnt7b and Wnt11 are the  
non-canonical Wnts[11]. However, some Wnt proteins have both canonical and non- 
canonical properties – for example, Wnt5a, which is considered a non-canonical Wnt, was  
found to be able to induce secondary axis formation when the receptor Fz5 was present[12].  
Therefore, some non-canonical Wnts may initiate canonical Wnt signaling when bound to  
specific Wnt receptors. 
    Of all the wingless proteins, Wnt5a is particularly interesting. It is known to have significant  
roles in the development process of various organs and postnatal functions. Recent reports  
demonstrated that abnormalities in Wnt5a signaling are involved in cancers, inflammatory  
diseases, and metabolic diseases[13].  
    Wnt5a is strongly associated with inflammatory responses. As stated above, Wnt5a  
 
induces inflammatory process through non-canonical pathway. There are several studies  
 
supporting this statement. An important study in Drosophila by Gordon’s group is considered  
 
to be the first direct evidence of the function of Wnt pathway in inflammation and immunity.  
 
They demonstrated that the Drosophila Wnt protein family member WntD is upregulated in  
 
the fly via Toll/nuclear factor-kB (NF-kB) signaling and shown to be involved in antibacterial  
 
defense against Listeria monocytogenes in a septic fly model[14].  Later on, Blumenthal’s  
 
study in humans also demonstrated that Toll/NF-kB is required for the upregulation of Wnt5a  
 
in response to microbial challenge [15]. Furthermore, this study also demonstrated that  
 
Wnt5a upregulates the microbially-induced IL-12 response of antigen-presenting cells and  
 
IFN-γ production by mycobacterial antigen-stimulated T-cells, illustrating a functional  
 
involvement in the antimicrobial defense. This suggested the involvement of Wnt signaling in  
 
innate and adaptive immunity to infections.  
 
    Recent study by Divaris et al also suggested significance of Wnt5a in pathology of chronic  
 
periodontitis. They presented the results of a genome-wide association study of chronic  
 periodontitis and detected association of Wnt5a with severe chronic periodontitis[16]. These  
 
findings indicate that wnt5a may be involved in inflammatory diseases and thus might be an  
 
attractive candidate for therapeutic intervention.  
 
    Frizzled protein is a surface receptor for Wnt proteins. From 10 Fzs, Wnt5a signaling can  
be mediated through at least Fz3, Fz4, Fz5 and Fz8[17]. It is suggested that Wnt5a regulates  
cellular functions by binding to several Fzs. The soluble frizzled related protein is a family of  
soluble proteins that are structurally related to Frizzled (Fz) proteins, the serpentine  
receptors that mediate the extensively used cell-cell communication pathway involving Wnt  
signaling. Because of their homology with the Wnt-binding domain on the Fz receptors,  
sFRPs sequester Wnt proteins in the extracellular space and prevent Wnt from binding to  
their receptors. They have therefore been characterized as antagonists that bind to Wnt  
proteins to prevent signal activation[18]. The soluble frizzled related protein (sFRP)-5 is a  
known inhibitor of wnt5a signaling[19].  
    Dominik and colleagues measured Wnt5a and sFRP5 serum concentrations in lean control  
subjects and patients with obesity. They found that pro-inflammatory Wnt5a was not  
measurable in any serum sample of lean control subjects. In patients with obesity, however,  
Wnt5a was significantly upregulated consistent with low-grade inflammation in such subjects.  
sFRP5 was detected in both groups with no significant difference. Interestingly, after caloric  
restriction, there was a significant increase in serum concentrations of sFRP5. Furthermore,  
they found that adipose tissue macrophages of obese and type 2 diabetic human subjects  
express wnt5a secreted by macrophage and inhibits differentiation of pre-adipocytes.  
    These recent findings suggest that Wnt5a might act as an important pro-inflammatory  
molecule in low-grade inflammation of adipose tissue in obese humans, whereas sFRP5  
may play an anti-inflammatory role [20]. Since both obesity and periodontitis are  
inflammatory diseases, these studies prompted us to study the expression of Wnt5a and  
sFRP5 in periodontitis tissue and healthy tissue in order to dissect the possible roles of   
Wnt5a and sFRP5 in the periodontal tissue in health and disease. It should be noted that  
knowledge about the expression and modulation of Wnt homologs in inflammatory settings,  
such as periodontitis, is still limited. A study demonstrated that Wnt5a mRNA expression was  
up-regulated in chronic periodontitis tissue as compared to healthy control tissue using RT- 
PCR[21]. However, no study thus far has investigated how the expression of Wnt5a is  
correlated with sFRP5 expression in periodontitis and healthy tissue. We expect that our  
approach will advance the knowledge of Wnt5a and sFRP5 in the progression and  
prevention of periodontitis and serve as a platform for the development of new therapies. 
 
Materials and methods 
 
Human samples 
 
Human gingival tissues were obtained during routine  periodontal surgeries and crown- 
 
lengthening surgeries conducted on 69 physically healthy adults in the University of  
 
Pennsylvania School of Dental Medicine Graduate Periodontics Clinic. Samples of gingival  
 
tissues were obtained from 29 individuals without periodontal disease (control group) during  
 
crown-lengthening surgery and 40 patients with generalized and localized moderate to  
 
severe chronic periodontitis. The PD, CAL of the sampling sites was evaluated using a  
 
periodontal probe (Hu-Friedy, Leimen, Germany). Research was performed under an  
 
Institutional Review Board–approved protocol and all donors provided informed consent. 
 
Immunohistochemistry 
 
Gingival biopsy specimens were fixed in 4% paraformaldehyde and embedded in OCT  
 
compound. Cryostat sections were cut at 8 µm and mounted on glass slides. The sections  
 
were fixed in PFA for 10 minutes, washed with mixed solution of  Phosphate buffered saline  
 
(PBS) and 0.1% Tween 20 followed by solution of PBS and 0.1% TritonX-100. Final rinse  
 
with PBS 15 minutes before incubation. Sections were stained using mouse monoclonal  
 
antibody against human Wnt5a (clone6F2, Lsbio), rabbit polyclonal antibody against human  
 
sFRP (Novus), followed by secondary reagents (Alexa Fluor 488–conjugated goat anti-rabbit  
 
IgG or Alexa Fluor 594–conjugated goat anti-mouse IgG,; Life Technologies). The specificity  
 
of staining was confirmed by using appropriate isotype controls or nonimmune rabbit IgG  
 
followed by Alexa Fluor 488– or Alexa Fluor 594–conjugated anti-IgG. Images were captured  
 
using a Nikon Eclipse NiE automated upright fluorescent microscope. 
 
Quantitative real-time PCR (qPCR) 
 
Total RNA was extracted from excised gingival tissue or cultured cells using the PerfectPure 
 
RNA cell kit (5 Prime, Fisher) and quantified by spectrometry at 260 and 280 nm. The RNA  
 
was reverse-transcribed using the High Capacity RNA-to-cDNA Kit (Life Technologies) and  
 
qPCR with cDNA was performed using the Applied Biosystems 7500 Fast Real-Time PCR  
 
System according to the manufacturer's protocol (Life Technologies). Data were analyzed  
 
using the comparative (∆∆Ct) method. TaqMan probes, sense primers, and antisense  
 
primers for detection and quantification of genes investigated in this paper were purchased  
 
from Life Technologies.  
 
Cell preparation and culture 
 
Human gingival epithelial cells (HGECs) were prepared from clinically normal gingival tissue.  
 
The tissues were treated overnight with Dulbecco’s modified minimal essential medium  
 
(DMEM) containing 0.025% trypsin and 0.01% EDTA. After washing with PBS and  
 
subsequent chopping into small pieces, the tissues were suspended in Epilife, containing  
 
supplement S7 and penicillin–streptomycin– amphotericin B solution (all from Invitrogen).  
 
The tissues were removed when the cells started to grow and were maintained until the cells  
 
reached confluence. For the stimulation experiments, HGECs were seeded into a 12-well  
 
culture plate. After 24 h of incubation, the attached cells were washed extensively with Epilife  
 
and co-cultured with 100ng/mL of P. gingivalis LPS (Invivogen), 100ng/mL of E. coli LPS  
 
(Invivogen), Wnt5a 300ng/ml (R&D) or sFRP5 500ng/ml (R&D) in Epilife containing  
 
Supplement S7 for 12 h (gene expression assay) or 24 h (Chemokine assay). 
 
Chemokine assay 
 
The level of IL-8 in the supernatants of HGECs culture were determined by using  
 commercially available ELISA kits (eBioScience) according to the manufacturer’s instructions. 
 
Statistical Analysis 
 
Results were expressed as the mean ± standard error of the mean. When two groups were  
 
compared, unpaired t test was used. Multiple comparisons were performed by ANOVA- 
 
Williams test was used for post hoc comparisons. A probability value <0.05 was considered  
 
statistically significant. 
 
Results 
 
Localization of Wnt5a and sFRP5 in periodontal tissue 
 
To determine the localization of Wnt5a and sFRP5 protein expression in periodontal tissue,  
 
we performed immunohistochemistry of periodontal biopsy specimens. Expression of sFRP5  
 
was much stronger in healthy tissue compared to diseased periodontal tissue (Fig. 1). In  
 
contrast, Wnt5a expression was comparable in diseased and healthy tissue. Both Wnt5a and  
 
sFRP5 were expressed in the epithelial layer but not in the connective tissue. 
 
Gene expressions of Wnt5a and sFRP5 in human periodontal tissue 
 
We next investigated the gene expressions of Wnt5a and sFRP5 in human periodontal tissue.  
 
We found that sFRP5 expression was upregulated in healthy tissue relative to its  
 
expression in diseased tissue (Fig. 2), consistent with our immunohistochemical  
 
observations. On the other hand, Wnt5a expression was increased in periodontitis tissue as  
 
compared with healthy tissue (Fig. 2). Although Wnt5a expressed comparably in both health  
 
and diseased periodontal tissues in IHC, its mRNA expression was significantly upregulated  
 
in diseased tissue.  
 
Effects of LPS on Wnt5a and sFRP5 expression in HGECs 
 
Although P. gingivalis LPS can induce inflammatory cytokine, it is not clear whether these  
 
affect Wnt5a and sFRP5 expression.  First, we isolated HGECs from healthy patient. Both  
 
stimuli used, LPS from P. gingivalis or E. coli, induced Wnt5a expression and reduced  
 
sFRP5 expression (Fig. 3).  
 
sFRP5 inhibited chemokine production in HGECs 
 
To determine whether sFRP5 mediates anti-inflammatory effects, HGECs were treated with  
 
both Wnt5a and LPS in the presence or absence of sFRP5.  Importantly, the production of  
 
IL-8 in HGECs was significantly inhibited in the presence of sFRP5 (Fig. 4). 
 
Discussion 
 
     Wnt5a is strongly associated with inflammatory responses as shown by several studies.  
 
Wnt5a was found to be a proinflammatory molecule that stimulates inflammatory function of  
 
antigen-presenting cells, such as macrophages[15, 21-23].  
     
    Interestingly, our immunofluorescent staining demonstrated that Wnt5a and sFRP5 were  
 
expressed in epithelial layer of gingival tissues. Furthermore, Wnt5a and sFRP5 were co- 
 
localized. More pronounced expression of sFRP5 in healthy group than in periodontitis group  
 
was observed; however, the expression level of Wnt5a was found to be similar in both  
 
groups. Difference was noted in merged Wnt5a and sFRP5 images of periodontitis and  
 
healthy group in a way that Wnt5a appeared to predominate over sFRP5 expression in  
 
periodontitis group and vice versa in the healthy group. Periodontitis tissues in this  
 
experiment were obtained from periodontal surgeries. These tissues were periodontally  
 
treated previously, thus it is likely that inflammation was not as pronounced as in cases of  
 
untreated periodontitis. This might explain why we did not detect an obvious difference in the  
 
levels of Wnt5a expression between periodontitis and healthy group. Results from the  
 
immunofluorescent study showed clearly that Wnt5a and Sfrp5 were expressed in the  
 
epithelial layer.  
      
     This led to the next step of quantitative analysis of Wnt5a and sFRP5 mRNA expression  
 
using qPCR in both groups. Wnt5a mRNA was shown to be significantly higher in  
 
periodontitis group when compared to healthy group. sFRP5 mRNA expression, on the  
 
contrary, was shown to be significantly higher in healthy group. These results confirm our  
 
hypothesis that the expression of the proinflammatory Wnt5a is more pronounced in inflamed  
 
tissues and expression of the anti-inflammatory sFRP5 is more pronounced in healthy  
 tissues. Our findings agree with Nanbara’s study [21], which showed significantly higher  
 
Wnt5a mRNA expression in periodontitis tissues, although they did not examine the  
 
expression of Wnt5a protein. Moreover, we are the first group that investigated the  
 
expression of sFRP5 mRNA and protein in periodontitis and healthy gingival tissues.  
      
     In order to confirm our speculation that gingival epithelial cells express Wnt5a and sFRP5,  
 
another qPCR experiment was set up. Results clearly demonstrated that Wnt5a and sFRP5  
 
mRNA were expressed by human gingival epithelial cells. Furthermore, modulation of Wnt5a  
 
and sFRP5 expression by periodontal bacteria was also investigated. Wnt5a mRNA was  
 
highly upregulated in the presence of P. gingivalis when compared to unstimulated group  
 
and E. coli challenged group. The significance of P. gingivalis in the pathogenesis of  
 
periodontitis is well documented. P. gingivalis is a keystone pathogen in periodontitis which  
 
subverts the host response and tips the balance from homeostasis to dysbiosis.  
        
     As shown by this study that Wnt5a mRNA was highly up-regulated in the presence of P.  
 
gingivalis when compared to unstimulated group. In contrast, sFRP5 mRNA was suppressed  
 
in the presence of P. gingivalis and E. coli.  
      
      As stated previously, Wnt5a was found to be involved in a large number of inflammatory  
 
diseases. Kim’s group demonstrated up-regulation of inflammatory cytokines, for example,  
 
IL-8, IL-6 etc. by Wnt5a in endothelial cells through the Wnt-Ca2+ signaling pathway[24]. IL- 
 
8 is a chemokine which mainly attracts neutrophils to sites of inflammation. It is up-regulated  
 
by pro-inflammatory cytokines such as TNF-α and IL-1, bacterial or viral products. Increased  
 
expressions of IL-8 and neutrophil accumulation have been shown to be involved in the  
 
pathology of periodontitis[25]. Another experiment was set up to study the level of IL-8  
 
mRNA expression using qPCR.  Human gingival epithelial cells challenged with Wnt5a or P.  
 
gingivalis LPS showed more expression of IL-8 while P. gingivalis LPS combined with Wnt5a  
 
triggered the most pronounced IL-8 mRNA expression. This demonstrates synergistic effect  
 
of P. gingivalis LPS and proinflammatory Wnt5a in eliciting inflammation. In contrast, P.  
 
gingivalis LPS combined with sFRP5 decreased expression of IL-8 mRNA compared to  
 
stimulation with P. gingivalis LPS alone. This demonstrates antagonistic effect of P.  
 
gingivalis LPS and anti-inflammatory sFRP5.  ELISA experiment confirmed these results at  
 
the cytokine protein level.  
      
      Overall, it’s shown from our study that Wnt5a and sFRP5 have important roles in  
 
inflammatory process of periodontitis. Wnt5a usually stimulates non-canonical Wnt signaling  
 
which consists of at least three different B-catenin-independent pathways, the Wnt/PCP,  
 
Wnt/Ca2+, and Wnt/ROR2. Interestingly, CAMKII and PKC which are products from  
 
Wnt/Ca2+ pathway have been shown to block the Wnt canonical pathway[26]. Moreover,  
 
Wnt/ROR2 pathway also can inhibit the canonical pathway[27]. In periodontitis, canonical  
 
pathway is known to regulate bone homeostasis. Activation of canonical pathway leads to  
 
more bone formation; on the contrary, inhibition of this pathway leads to bone destruction[28,  
 
29]. On the basis of the above-discussed findings, we can speculate that apart from the  
 
ability of Wnt5a to enhance inflammation through non-canonical pathways, mediators  
 
induced via non-canonical pathways can also contribute to blockage of canonical pathway  
 
and thus lead to further bone destruction.  
      
     Ouchi’s group conducted experiment in sFRP5 knockout mice, which were put on high- 
 
calorie diet. They observed systemic metabolic dysfunction and severe adipose tissue  
 
inflammation. However, administration of sFRP5 improved metabolic function and down- 
 
regulated adipose tissue inflammation[19]. A similar approach could be applied to the  
 
treatment of periodontitis. Our study found higher level of sFRP5 in healthy gingival tissues  
 
when compared to periodontitis tissues. sFRP5 also interferes with inflammatory chemokine  
 
expression induced by Wnt5a or P. gingivalis LPS. Our results therefore suggest a role of  
 
sFRP5 as a potential anti-inflammatory molecule in periodontitis.  
 
Conclusion 
 
We have shown for the first time an inverse correlation between Wnt5a and sFRP5 in  
 
periodontal disease vs. health. We have moreover shown for the first time that both  
 molecules can be expressed by human gingival epithelial cells. Wnt5a appears to be an  
 
important target for intervention in periodontitis and in this context, sFRP5 is likely a  
 
promising therapeutic compound. This notion could be tested in future studies in preclinical  
 
models, hopefully paving the way for clinical trials. 
 
FIGURE LEGENDS 
Figure. 1. Expression of Wnt5a and sFRP5 in sections of periodontal specimens. Periodontal  
biopsy specimens from healthy and periodontitis patients were processed for  
immunofluorescence and hematoxylin and eosin staining. Overlays of differential  
interference contrast (DIC) and fluorescent images stained for wnt5a (red) and sFRP5  
(green) are shown. Scale bar, 50 µm. 
 
Figure. 2. Gene expression of Wnt5a and sFRP5 in periodontal tissue. The mRNA  
expression levels were normalized against GAPDH mRNA. Data are means ± SD (N=9   
healthy, N=8 periodontitis) . *p < 0.01. 
 
Figure. 3. LPS increases Wnt5a expression and inhibites sFRP5 expression. HGECs were 
stimulated for 12 h with P. gingivalis lipopolysaccharide (Pg LPS; 100ng/ml or 1 µg/mL), E. coli 
LPS (Ec LPS; 100ng/ml or 1 µg/mL). Data are means ± SD (n = 5 sets of cells). *p < 0.01 
compared with no pretreatment. 
 
Figure. 4. sFRP5 inhibit production of chemokine IL-8 by Wnt5a and Pg LPS stimulation. 
HGECs were pretreated for 1 h with sFRP5 (500ng/ml), followed by 12 h (mRNA) or 24 h 
(chemokine assay) stimulation with medium only or with Pg LPS; 100ng/ml or Wnt5a (300ng/ml). 
Subsequently, mRNA was collected for gene expression assay and culture supernatants were 
collected for measuring IL-8 by ELISA. Data are means ± SD (n = 5 sets of cells). *p < 0.01. 
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